NO20050398L - Nye adenosinanaloger og deres anvendelse som farmasoytiske midler - Google Patents
Nye adenosinanaloger og deres anvendelse som farmasoytiske midlerInfo
- Publication number
- NO20050398L NO20050398L NO20050398A NO20050398A NO20050398L NO 20050398 L NO20050398 L NO 20050398L NO 20050398 A NO20050398 A NO 20050398A NO 20050398 A NO20050398 A NO 20050398A NO 20050398 L NO20050398 L NO 20050398L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical agents
- adenosine analogues
- new adenosine
- compounds
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Foreliggende oppfinnelse angår forbindelser med generell formel (I), hvoii R*, A, B, Q, T, W og X har betydningene gitt i beskrivelsen. Disse forbindelsene er anvendelige for fremstilling av et medikament for behandling av insulim-esisens, type 2 diabetes, meta- bolittisk syndrom, lipidforstyrrelser eller kardiovaskulær sykdom, eller for å tilveie- bringe en anti-lipolyttisk effekt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02014324A EP1375508A1 (en) | 2002-06-27 | 2002-06-27 | N6-substituted adenosine analogues and their use as pharmaceutical agents |
PCT/EP2003/006749 WO2004003002A1 (en) | 2002-06-27 | 2003-06-26 | Novel adenosine analogues and their use as pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050398L true NO20050398L (no) | 2005-01-25 |
Family
ID=29716849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050398A NO20050398L (no) | 2002-06-27 | 2005-01-25 | Nye adenosinanaloger og deres anvendelse som farmasoytiske midler |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP1375508A1 (no) |
JP (1) | JP2006501178A (no) |
KR (1) | KR20050014888A (no) |
CN (1) | CN1671728A (no) |
AR (1) | AR039697A1 (no) |
AU (1) | AU2003280141A1 (no) |
BR (1) | BR0312428A (no) |
CA (1) | CA2490253A1 (no) |
HR (1) | HRP20041209A2 (no) |
IL (1) | IL165934A0 (no) |
MA (1) | MA27465A1 (no) |
MX (1) | MXPA04012815A (no) |
NO (1) | NO20050398L (no) |
PE (1) | PE20040584A1 (no) |
PL (1) | PL375197A1 (no) |
RU (1) | RU2005101872A (no) |
TW (1) | TW200500376A (no) |
WO (1) | WO2004003002A1 (no) |
ZA (1) | ZA200410062B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1928821E (pt) | 2005-09-21 | 2009-03-10 | Pfizer Ltd | Derivados de carboxamida enquanto antagonistas dos receptores muscarínicos |
JP2007153789A (ja) * | 2005-12-05 | 2007-06-21 | Mitsui Chemicals Inc | 光学活性3−アミノピロリジン誘導体の製造方法 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545645A1 (de) * | 1965-12-06 | 1969-08-21 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten |
AU575438B2 (en) * | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
WO1988003147A1 (en) * | 1986-10-31 | 1988-05-05 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
WO1997033591A1 (en) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
US6376472B1 (en) * | 1996-07-08 | 2002-04-23 | Aventis Pharmaceuticals, Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
UA51716C2 (uk) * | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
AU7449598A (en) * | 1997-05-23 | 1998-12-11 | Nippon Shinyaku Co. Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
GB9723566D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
GB9723589D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-06-27 EP EP02014324A patent/EP1375508A1/en not_active Withdrawn
-
2003
- 2003-06-18 AR ARP030102151A patent/AR039697A1/es unknown
- 2003-06-25 PE PE2003000640A patent/PE20040584A1/es not_active Application Discontinuation
- 2003-06-26 EP EP03740352A patent/EP1527083A1/en not_active Withdrawn
- 2003-06-26 MX MXPA04012815A patent/MXPA04012815A/es not_active Application Discontinuation
- 2003-06-26 PL PL03375197A patent/PL375197A1/xx not_active Application Discontinuation
- 2003-06-26 TW TW092117351A patent/TW200500376A/zh unknown
- 2003-06-26 AU AU2003280141A patent/AU2003280141A1/en not_active Abandoned
- 2003-06-26 CA CA002490253A patent/CA2490253A1/en not_active Abandoned
- 2003-06-26 BR BR0312428-2A patent/BR0312428A/pt not_active IP Right Cessation
- 2003-06-26 KR KR10-2004-7021262A patent/KR20050014888A/ko not_active Application Discontinuation
- 2003-06-26 IL IL16593403A patent/IL165934A0/xx unknown
- 2003-06-26 RU RU2005101872/04A patent/RU2005101872A/ru not_active Application Discontinuation
- 2003-06-26 WO PCT/EP2003/006749 patent/WO2004003002A1/en active Application Filing
- 2003-06-26 JP JP2004516688A patent/JP2006501178A/ja active Pending
- 2003-06-26 CN CNA038179660A patent/CN1671728A/zh active Pending
-
2004
- 2004-12-13 ZA ZA200410062A patent/ZA200410062B/xx unknown
- 2004-12-24 HR HR20041209A patent/HRP20041209A2/hr not_active Application Discontinuation
- 2004-12-24 MA MA28022A patent/MA27465A1/fr unknown
-
2005
- 2005-01-25 NO NO20050398A patent/NO20050398L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04012815A (es) | 2005-02-24 |
EP1375508A1 (en) | 2004-01-02 |
EP1527083A1 (en) | 2005-05-04 |
HRP20041209A2 (en) | 2005-08-31 |
AR039697A1 (es) | 2005-03-09 |
RU2005101872A (ru) | 2005-08-10 |
TW200500376A (en) | 2005-01-01 |
CA2490253A1 (en) | 2004-01-08 |
WO2004003002A1 (en) | 2004-01-08 |
KR20050014888A (ko) | 2005-02-07 |
PE20040584A1 (es) | 2004-11-03 |
ZA200410062B (en) | 2008-08-27 |
AU2003280141A1 (en) | 2004-01-19 |
IL165934A0 (en) | 2006-01-15 |
CN1671728A (zh) | 2005-09-21 |
PL375197A1 (en) | 2005-11-28 |
BR0312428A (pt) | 2005-04-26 |
JP2006501178A (ja) | 2006-01-12 |
MA27465A1 (fr) | 2005-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
NO20081482L (no) | Delta- og epsilon-krystallformer for imatinibmesylat | |
NO20054876L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
MX2008002062A (es) | Uso de derivados de tienopiridona como activadores de ampk y composiciones farmaceuticas que los contienen. | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
NO20091229L (no) | Kombinasjonsterapi med SGLT-2 inhibitorer og deres farmasoytiske sammensetninger | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
MX2008012017A (es) | Pirazoles como inhibidores de 11-beta-hsd1. | |
CY1108900T1 (el) | Πολυθειωμενα γλυκοζιδια και αλατα αυτων | |
MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
NO20065904L (no) | Terapeutiske forbindelser | |
NO20054868L (no) | CaSr antagonist | |
NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
SE0102299D0 (sv) | Compounds | |
SE0102300D0 (sv) | Compounds | |
WO2008042688A3 (en) | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 | |
NO20050828L (no) | lndol-3-svovelderivater | |
NO20070089L (no) | DPP-IV inhibitorer | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |